LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis GBX 52 -0.90 (-1.70%) As of 03/28/2025 12:36 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Dr. Martens Stock (LON:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Martens alerts:Sign Up Key Stats Today's Range 51.55▼ 54.4550-Day Range 52▼ 74.6552-Week Range 49.32▼ 99.40Volume848,501 shsAverage Volume2.76 million shsMarket Capitalization£504.80 millionP/E Ratio7.37Dividend Yield5.77%Price TargetN/AConsensus RatingN/A Company OverviewDr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.Read More… Remove Ads Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesDr. Martens plc (LON:DOCS) Insider Giles Wilson Acquires 32,640 SharesMarch 27 at 1:16 AM | insidertrades.comDr. Martens plc (LON:DOCS) Insider Acquires £150.64 in StockMarch 13, 2025 | insidertrades.comElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.March 29, 2025 | True Market Insiders (Ad)Dr. Martens 'versatile' sandals that are so good shoppers are 'buying multiple' get a £40 price cut3486075334860753March 23, 2025 | mirror.co.ukDr Marten launch leopard print mules shoppers are calling their ‘favourite shoes ever’March 14, 2025 | mirror.co.ukDr Martens spring sale: snag platform sandals and more for under $100 while supplies lastMarch 14, 2025 | msn.comDr. Martens' 'Dependable and Stylish' Lace-Up Boots That Are 'Built to Last a Lifetime' Are 30% Off Right NowMarch 5, 2025 | msn.comDr. Martens Selects Amperity to Transform Customer Data StrategyMarch 4, 2025 | finance.yahoo.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Dr. Martens' stock was trading at GBX 72.20 at the start of the year. Since then, DOCS shares have decreased by 28.0% and is now trading at GBX 52. View the best growth stocks for 2025 here. How were Dr. Martens' earnings last quarter? Dr. Martens plc (LON:DOCS) released its quarterly earnings results on Thursday, November, 28th. The company reported ($1.30) EPS for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Dr. Martens own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY). Company Calendar Last Earnings11/28/2024Record date for 4/8 Dividend3/06/2025Ex-Dividend for 4/8 Dividend3/06/2025Today3/29/2025Dividend Payable4/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryComputer Software Current SymbolLON:DOCS CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees890Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 7.05 Trailing P/E Ratio7.37 Forward P/E Ratio20.15 P/E Growth6.4Net Income£68.97 million Net Margins7.89% Pretax MarginN/A Return on Equity18.91% Return on Assets8.12% Debt Debt-to-Equity Ratio127.27 Current Ratio2.85 Quick Ratio1.13 Sales & Book Value Annual Sales£874.20 million Price / Sales0.58 Cash FlowGBX 3.64 per share Price / Cash Flow14.29 Book ValueGBX 37.80 per share Price / Book1.38Miscellaneous Outstanding Shares970,763,405Free FloatN/AMarket Cap£504.80 million OptionableNot Optionable Beta0.11 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (LON:DOCS) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.